Nadina Erill

778 total citations
16 papers, 450 citations indexed

About

Nadina Erill is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nadina Erill has authored 16 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Nadina Erill's work include Ovarian cancer diagnosis and treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Nadina Erill is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Nadina Erill collaborates with scholars based in Spain, United States and Switzerland. Nadina Erill's co-authors include Míriam Cuatrecasas, Eva Musulén, Jaime Prat, Irmgard Costa, Xavier Matías‐Guiu, Jordi Barbé, Susana Campoy, Ivan Erill, Jordi Aguiló and Carlos Cordon‐Cardo and has published in prestigious journals such as Gastroenterology, Cancer and Clinical Cancer Research.

In The Last Decade

Nadina Erill

15 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadina Erill Spain	11	166	155	95	89	79	16	450
Magdalena Potoczek United States	11	162 1.0×	321 2.1×	60 0.6×	161 1.8×	17 0.2×	16	589
Ying L. Liu United States	14	198 1.2×	104 0.7×	77 0.8×	124 1.4×	135 1.7×	48	481
José L. García-Puche Spain	11	258 1.6×	257 1.7×	61 0.6×	313 3.5×	19 0.2×	21	551
Marie‐Aude Le Frère‐Belda France	12	152 0.9×	73 0.5×	110 1.2×	60 0.7×	130 1.6×	31	482
Hanna Sallinen Finland	14	95 0.6×	197 1.3×	29 0.3×	77 0.9×	172 2.2×	24	394
Chris Zahn United States	7	109 0.7×	120 0.8×	43 0.5×	57 0.6×	114 1.4×	9	314
Per J. Bøhler Norway	13	151 0.9×	196 1.3×	53 0.6×	170 1.9×	19 0.2×	21	481
Suxia Lin China	10	301 1.8×	202 1.3×	60 0.6×	126 1.4×	46 0.6×	18	616
Micaela Morgado United States	9	366 2.2×	169 1.1×	36 0.4×	84 0.9×	30 0.4×	12	641
Marie Gamarra United States	10	105 0.6×	106 0.7×	132 1.4×	52 0.6×	64 0.8×	18	372

Countries citing papers authored by Nadina Erill

Since Specialization

Citations

This map shows the geographic impact of Nadina Erill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadina Erill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadina Erill more than expected).

Fields of papers citing papers by Nadina Erill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadina Erill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadina Erill. The network helps show where Nadina Erill may publish in the future.

Co-authorship network of co-authors of Nadina Erill

This figure shows the co-authorship network connecting the top 25 collaborators of Nadina Erill. A scholar is included among the top collaborators of Nadina Erill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadina Erill. Nadina Erill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Pujol-Canadell, Mònica, Juan S. López, E. Martinez, et al.. (2025). Correlation between DNA double strand breaks and cell death in peripheral blood lymphocytes from breast cancer patients. International Journal of Radiation Biology. 101(10). 1027–1037.

Puig, Pere, Nadina Erill, Isaac Subirana, et al.. (2019). Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer. BMC Research Notes. 12(1). 68–68. 2 indexed citations

Santiago, Llipsy, Cheikh Menaa, Maykel Arias, et al.. (2016). Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis. Arthritis & Rheumatology. 69(2). 320–334. 31 indexed citations

Marín‐Aguilera, Mercedes, Òscar Reig, Juan José Lozano, et al.. (2015). Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer. Oncotarget. 6(12). 10604–10616. 21 indexed citations

Gallego, Óscar, Míriam Cuatrecasas, Manuel Benavides, et al.. (2013). Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry. Journal of Neuro-Oncology. 116(2). 413–419. 31 indexed citations

Sänchez‐Carbayo, Marta, et al.. (2007). A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer. Clinical Cancer Research. 13(11). 3215–3220. 51 indexed citations

Colomer, Anna, Nadina Erill, August Vidal, et al.. (2005). A Novel Logistic Model Based on Clinicopathological Features Predicts Microsatellite Instability in Colorectal Carcinomas. Diagnostic Molecular Pathology. 14(4). 213–223. 10 indexed citations

Erill, Nadina, Anna Colomer, Miquel Calvo, et al.. (2005). A Novel Multiplexing, Polymerase Chain Reaction-Based Assay for the Analysis of Chromosome 18q Status in Colorectal Cancer. Journal of Molecular Diagnostics. 7(4). 478–485. 6 indexed citations

Erill, Nadina, Anna Colomer, Ruth Román, et al.. (2004). Genetic and Immunophenotype Analyses of TP53 in Bladder Cancer. Diagnostic Molecular Pathology. 13(4). 217–223. 30 indexed citations

10.

Colomer, Anna, Nadina Erill, Ruth Román, et al.. (2003). Lack of p53 Nuclear Immunostaining Is Not Indicative of Absence of TP53 Gene Mutations in Colorectal Adenocarcinomas. Applied immunohistochemistry & molecular morphology. 11(2). 130–137. 17 indexed citations

11.

Erill, Ivan, Susana Campoy, Nadina Erill, Jordi Barbé, & Jordi Aguiló. (2003). Biochemical analysis and optimization of inhibition and adsorption phenomena in glass–silicon PCR-chips. Sensors and Actuators B Chemical. 96(3). 685–692. 78 indexed citations

12.

Cuatrecasas, Míriam, Nadina Erill, Eva Musulén, et al.. (1998). K‐ras mutations in nonmucinous ovarian epithelial tumors. Cancer. 82(6). 1088–1095. 9 indexed citations

13.

Cuatrecasas, Míriam, Nadina Erill, Eva Musulén, et al.. (1998). K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients.. PubMed. 82(6). 1088–95. 56 indexed citations

14.

Cuatrecasas, Míriam, Nadina Erill, Eva Musulén, et al.. (1998). K-ras mutations in nonmucinous ovarian epithelial tumors. Cancer. 82(6). 1088–1095. 39 indexed citations

15.

Erill, Nadina, et al.. (1996). K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.. PubMed. 149(4). 1333–9. 16 indexed citations

16.

Reyes, Guillermo Yanowsky, Míriam Cuatrecasas, Nadina Erill, et al.. (1996). Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses. Gastroenterology. 110(5). 1587–1594. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact